Iopofosine I 131 is a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a radioconjugate monotherapy. The FDA previously granted Orphan Drug Designation for ...
Tia, the leading provider of whole-person women’s healthcare, today announced the launch of its Hormone & Vitality Assessment ...
A new study adds to the evidence that viral infections during pregnancy might contribute to a child’s likelihood of having autism ...
Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...
The shrinking options are leading to lapses in care and delays in time-sensitive treatments. “It’s basically an abandonment ...
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...
Editor's Note: Some of the language in this story includes details from three lawsuits filed against the city of Holly Hill that some readers may find graphic and disturbing. HOLLY HILL, Fla. — Three ...
CLEARWATER, Fla. — Desnee Ebner-Rivers and the word, "cancer," do not get along. Not because she has cancer, but because of what it has taken from her. “I did. I lost all of them," said Ebner-Rivers.
Place of Nursing Theory during Cardiac Arrest Management: Case of HPRC and CPLR in Bujumbura. Open Journal of Nursing, 15, 941-948. doi: 10.4236/ojn.2025.1510067 . Cardiac arrest is a major public ...
Scientists are learning more about this leading complication of childbirth. Treatments are improving and doctors can test for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback